Opyl Limited (ASX:OPL)

Market Cap	5.40M
Revenue (ttm)	196.10K
Net Income (ttm)	-2.54M
Shares Out	192.86M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	572,547
Average Volume	1,573,704
Open	0.0280
Previous Close	0.0280
Day's Range	0.0280 - 0.0300
52-Week Range	0.0140 - 0.0330
Beta	1.03
RSI	68.01
Earnings Date	Aug 29, 2025

About Opyl Limited

Opyl Limited engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process for biopharma, MedTech, government, and healthcare organizations. The company was formerly known as ShareRoot Limite...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1994
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: OPL

Financial Performance

In 2024, Opyl Limited's revenue was 397,637, a decrease of -35.65% compared to the previous year's 617,907. Losses were -3.13 million, 81.3% more than in 2023.